Composite endpoint (including all‐cause mortality, non‐fatal myocardial infarction and/or any new stroke assessed at 30 days after surgery) · people undergoing CABG (with or without valve surgery)
RIPC showed no clear difference in composite endpoint (including all‐cause mortality, non‐fatal… compared with no RIPC (moderate certainty).
1 finding from 1 review
cTnT 72 h after surgery (ng/L) · people undergoing CABG (with or without valve surgery)
RIPC showed no clear difference in cTnT 72 h after surgery (ng/L) compared with no RIPC (moderate certainty).
1 finding from 1 review
cTnI 72 h after surgery (ng/L) · people undergoing CABG (with or without valve surgery)
RIPC showed no clear difference in cTnI 72 h after surgery (ng/L) compared with no RIPC (moderate certainty).
1 finding from 1 review
Intervention not reported
Peak IL‐6 (between the end of surgery and 24 hours post‐surgery)
1 finding from 1 review
Intervention not reported
Peak IL‐8 (between the end of surgery and 6 hours post‐surgery)
1 finding from 1 review
Coronary artery bypass graft surgery · Adults with coronary heart disease
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Coronary artery bypass graft surgery · overweight or obese adults
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Coronary artery bypass graft surgery · Free‐living adults who were healthy, had established cardiovascular disease or risk factors for cardiovascular disease
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Clinically important non‐fatal end point as defined byShores 1994(aortic dissection, aortic regurgitation, congestive heart failure, or cardiovascular surgery) · people with confirmed diagnosis of Marfan syndrome
Beta‐blockers showed no clear difference in clinically important non‐fatal end point as defined byShores… compared with placebo, no treatment or surveillance only (low certainty).
1 finding from 1 review
Cardiovascular surgery · people with confirmed diagnosis of Marfan syndrome
Beta‐blockers showed no clear difference in cardiovascular surgery compared with placebo, no treatment or surveillance only (low certainty).
1 finding from 1 review
Early postoperative mortality Deaths in the 30 days after surgery · patients with refractory angina
Transmyocardial laser revascularization showed no clear difference in early postoperative mortality Deaths in the 30 days after surgery compared with medical treatment (high certainty).
1 finding from 1 review
Mortality within the longest · adults diagnosed with coronary artery disease or cardiac valve disease, and candidates for cardiac surgery with cardiopulmonary bypass
Prophylactic corticosteroids showed no clear difference in all‐cause mortality (during the index hospital admission, or within… compared with placebo or no corticosteroids (low certainty).
1 finding from 1 review
Cardiac complications (as defined by study authors, including cardiac compromise and fatal and non‐fatal myocardial infarction, defined as ECG changes, echocardiological changes, or disproportionate elevation of troponins, during the index hospita... · adults diagnosed with coronary artery disease or cardiac valve disease, and candidates for cardiac surgery with cardiopulmonary bypass
Prophylactic corticosteroids may leads to higher cardiac complications (as defined by study authors, including… compared with placebo or no corticosteroids (low certainty).
1 finding from 1 review
Pulmonary complications (as defined by study authors, including pneumonia, embolism, reduced pulmonary function, prolonged ventilation, and pleural effusion, during the index hospital admission) · adults diagnosed with coronary artery disease or cardiac valve disease, and candidates for cardiac surgery with cardiopulmonary bypass
Prophylactic corticosteroids may leads to lower pulmonary complications (as defined by study authors, including… compared with placebo or no corticosteroids (low certainty).
1 finding from 1 review
Infectious complications · adults diagnosed with coronary artery disease or cardiac valve disease, and candidates for cardiac surgery with cardiopulmonary bypass
Prophylactic corticosteroids may leads to lower infectious complications (as defined by study authors, including… compared with placebo or no corticosteroids (low certainty).
1 finding from 1 review
Gastrointestinal bleeding · adults diagnosed with coronary artery disease or cardiac valve disease, and candidates for cardiac surgery with cardiopulmonary bypass
Prophylactic corticosteroids showed no clear difference in gastrointestinal (GI) bleeding (as defined by study authors,… compared with placebo or no corticosteroids (low certainty).
1 finding from 1 review
Renal failure · adults diagnosed with coronary artery disease or cardiac valve disease, and candidates for cardiac surgery with cardiopulmonary bypass
Prophylactic corticosteroids showed no clear difference in renal failure (as defined by study authors, including dialysis,… compared with placebo or no corticosteroids (low certainty).
1 finding from 1 review
Length of stay · adults diagnosed with coronary artery disease or cardiac valve disease, and candidates for cardiac surgery with cardiopulmonary bypass
1 finding from 1 review
Acute kidney injury · adults undergoing cardiac surgery with cardiopulmonary bypass
It is very uncertain whether high changes acute kidney injury compared with low blood pressure target (very low certainty).
1 finding from 1 review
Cognitive deterioration · adults undergoing cardiac surgery with cardiopulmonary bypass
High showed no clear difference in cognitive deterioration compared with low blood pressure target (low certainty).
1 finding from 1 review